Feature Channels: Immunology

Filters close

Not for public release

This news release is embargoed until 15-Apr-2024 5:00 PM EDT Released to reporters: 9-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Akiko Iwasaki, PhD, receives 2024 Tsukahara Memorial Award
Released: 15-Apr-2024 4:05 PM EDT
Akiko Iwasaki, PhD, receives 2024 Tsukahara Memorial Award
Yale School of Medicine

Yale School of Medicine immunobiologist Akiko Iwasaki, PhD, will receive the 2024 Nakaakira Tsukahara Memorial Award from the Brain Science Foundation of Japan.

Released: 15-Apr-2024 8:30 AM EDT
Dengue: An Emerging Global Crisis - Research and Expert Insights
Newswise Review

Calling All Experts and Researchers: Share Your Insights on Dengue, Prevention, Detection and Vaccines.

10-Apr-2024 10:05 AM EDT
Researchers Find No Link Between COVID-19 Virus and Development of Asthma in Children
Children's Hospital of Philadelphia

In the wake of the COVID-19 pandemic, many families worried about the long-term effects posed by the SARS-COV-2 virus. Now, researchers found that a SARS-COV-2 infection likely does not increase the risk of asthma development in pediatric patients. The findings were published today in the journal Pediatrics.

Newswise: Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV
Released: 10-Apr-2024 9:30 AM EDT
Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV
Wistar Institute

Wistar's Dr. Abdel-Mohsen has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV.

Released: 8-Apr-2024 8:05 PM EDT
A gene mutation associated with a rare neurological disorder and increased susceptibility to viral infections may be treatable with oleic acid
University of California, Los Angeles (UCLA), Health Sciences

A mutation in a protein regulating natural killer (NK) cells’ function is at the root of immune deficiency in some people with a rare genetic condition characterized by cognitive and developmental delay, seizures, and other manifestations. The findings also have broader implications for immunity and cell therapies.

Newswise: Announcing 2024 FASEB Excellence in Science Awards
5-Apr-2024 10:05 AM EDT
Announcing 2024 FASEB Excellence in Science Awards
Federation of American Societies for Experimental Biology (FASEB)

The Federation of American Societies for Experimental Biology (FASEB) bestows its highest honor, FASEB Excellence in Science Awards, to three women scientists.

   
2-Apr-2024 3:25 PM EDT
McMaster researchers create first-ever guidelines to help kids build tolerance to food allergens
McMaster University

Researchers with McMaster University have crafted the first-ever guidelines to help prepare families who plan to build their child’s tolerance to common food allergens.

Newswise: UT Southwestern scientists discover antiviral immune pathway
Released: 3-Apr-2024 12:05 PM EDT
UT Southwestern scientists discover antiviral immune pathway
UT Southwestern Medical Center

By focusing on a poxvirus protein, a team led by UT Southwestern Medical Center scientists has discovered an antiviral immune pathway that broadly fights a wide variety of viruses. Their findings, reported in Nature Microbiology, could eventually lead to new ways to prevent or treat viral infections or thwart autoimmune diseases.

Released: 2-Apr-2024 1:05 PM EDT
Received the COVID-19 vaccine but still got the disease? What Your COVID-19 Antibodies May Reveal About Your Recovery
Uniformed Services University of the Health Sciences (USU)

Wondering why some COVID-19 breakthrough cases feel milder than others? A groundbreaking study led by researchers at the Uniformed Services University (USU) sheds light on this phenomenon, offering insights into post-vaccination immunity dynamics.

Newswise: UTSW Research: Food allergies, weight-loss surgery, and more
Released: 2-Apr-2024 12:05 PM EDT
UTSW Research: Food allergies, weight-loss surgery, and more
UT Southwestern Medical Center

Roundup of recent research involving UT Southwestern faculty members: Antibody treatment lowers risk for food allergies; Weight-loss surgery support offered for teens; Racial disparities found among pregnant patients with multiple sclerosis; Gestational age increased at start of COVID-19 pandemic

Newswise: The Medical Minute: April fools vs. April facts
Released: 1-Apr-2024 6:05 PM EDT
The Medical Minute: April fools vs. April facts
Penn State Health

‘Tis the season of April trickery. Five Penn State health experts help you separate what’s real and what’s myth.

Newswise: Pete Savage appointed chair of Committee on Immunology at the University of Chicago
Released: 1-Apr-2024 5:05 PM EDT
Pete Savage appointed chair of Committee on Immunology at the University of Chicago
University of Chicago Medical Center

Savage succeeds Bana Jabri, who has chaired the committee since July 2020.

Released: 1-Apr-2024 2:05 PM EDT
Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases
Mayo Clinic

Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. 

Newswise: Researchers identify new way to inhibit immune cells that drive allergic asthma
19-Mar-2024 9:05 AM EDT
Researchers identify new way to inhibit immune cells that drive allergic asthma
The Rockefeller University Press

Researchers at the Keck School of Medicine, University of Southern California, have discovered that a protein called Piezo1 prevents a type of immune cell in the lung from becoming hyperactivated by allergens.

Released: 22-Mar-2024 9:00 AM EDT
AAI Announces Selection of 16 AAI Trainee Members as Major Symposium Speakers at the American Association of Immunologists’ IMMUNOLOGY2024™ Annual Conference
American Association of Immunologists (AAI)

The American Association of Immunologists today announced the selection of Trainee Members as a Major Symposium speakers for the IMMUNOLOGY2024™ meeting – the premier immunology conference bringing together the best minds, sharing cutting-edge research, and providing opportunities to connect –to be held in Chicago May 3-7, 2024.

   
Released: 21-Mar-2024 9:00 AM EDT
The American Association of Immunologists Announces Election of Association Officers and Committee Leadership
American Association of Immunologists (AAI)

The American Association of Immunologists (AAI) is proud to announce the outcome of its recent elections, in which voting members of the association selected the officers and committee leaders who will guide the organization in the years ahead.

   
Released: 20-Mar-2024 1:05 PM EDT
Experts warn climate change will fuel spread of infectious diseases
UC Davis Health

Infectious diseases specialists call the medical field to be ready to deal with the impact of climate change on spreading diseases, such as malaria, Valley fever, E-coli and Lyme disease.

Newswise: 1920_ibd-research-cedars-sinai-3.jpg?10000
Released: 19-Mar-2024 5:05 PM EDT
Genetics, Sex and Smoking Linked to More Health Issues for IBD Patients
Cedars-Sinai

Investigators at Cedars-Sinai have identified risk factors that make inflammatory bowel disease (IBD) patients susceptible to developing serious conditions in other parts of their bodies.

Released: 19-Mar-2024 1:40 PM EDT
New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections and Vaccines
University of Maryland School of Medicine

Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID.

Newswise: Managing Kids’ Seasonal Allergies Is Nothing to Sneeze at — Johns Hopkins Children’s Center Experts Available for Interviews
Released: 18-Mar-2024 9:00 AM EDT
Managing Kids’ Seasonal Allergies Is Nothing to Sneeze at — Johns Hopkins Children’s Center Experts Available for Interviews
Johns Hopkins Medicine

Spring will soon be in bloom, bringing runny and stuffy noses, sneezes and itchy, watery eyes.

13-Mar-2024 2:05 PM EDT
CHOP Researchers Discover Key Metabolic Process Responsible for Rapid Immune Responses
Children's Hospital of Philadelphia

Researchers identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.

Newswise: We Now Know Why Killer T Cells Lose Energy Inside of Solid Tumors
Released: 15-Mar-2024 11:05 AM EDT
We Now Know Why Killer T Cells Lose Energy Inside of Solid Tumors
University of North Carolina School of Medicine

Researchers at the UNC School of Medicine have found that a metabolic enzyme called Acetyl-CoA Carboxylase causes T cells to store fat when they are in solid tumors, rather than burning fat for energy.

Newswise: Nobel Laureate and NASA Astronaut to Speak at American Physiology Summit
Released: 15-Mar-2024 7:00 AM EDT
Nobel Laureate and NASA Astronaut to Speak at American Physiology Summit
American Physiological Society (APS)

Nobel Laureate Brian Kobilka, MD, and NASA Astronaut Jessica Meir, PhD, are among the highlighted speakers who will attend the American Physiology Summit, the American Physiological Society’s (APS) flagship annual meeting.

Newswise: Vac to the future
Released: 14-Mar-2024 3:05 PM EDT
Vac to the future
La Jolla Institute for Immunology

“We are hoping to use this competition not just as a way to examine the capacity of people to predict vaccination outcomes, but also as a way to address an important public health question,” says Peters.

Not for public release

This news release is embargoed until 14-Mar-2024 11:05 AM EDT Released to reporters: 14-Mar-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 11:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 13-Mar-2024 9:00 AM EDT
AAI Announces Esteemed 2024 Distinguished Fellows: Recognizing Excellence in Immunological Innovation and Leadership
American Association of Immunologists (AAI)

Recognizing exceptional scientific contributions and noteworthy service to the American Association of Immunologists (AAI) and the wider immunology community, AAI announces its 2024 class of Distinguished Fellows.

   
Newswise: Key protein linked to immune disorders
Released: 11-Mar-2024 10:00 PM EDT
Key protein linked to immune disorders
Hokkaido University

A new study highlights a potential therapeutic target for immune-related disorders, such as multiple sclerosis and asthma.

Released: 4-Mar-2024 4:05 PM EST
Breastfeeding after COVID-19 booster can give babies antibodies
University of Florida

A recently published study that shows lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine.

   
Newswise: Simmons Cancer Center awarded nearly $19 million in CPRIT funding
Released: 4-Mar-2024 11:05 AM EST
Simmons Cancer Center awarded nearly $19 million in CPRIT funding
UT Southwestern Medical Center

Nine scientists and physicians in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been awarded nearly $13 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research and prevention efforts on a wide range of cancer issues. UTSW received another $6 million for recruitment efforts.

Newswise: LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.
Released: 1-Mar-2024 12:05 AM EST
LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.
La Jolla Institute for Immunology

Cancer researcher Miguel Reina-Campos, Ph.D., has joined the faculty of La Jolla Institute for Immunology (LJI) as an Assistant Professor to lead the Laboratory of Tissue Immune Networks. His laboratory at LJI aims to investigate the basis of CD8+ T cell tissue immunity to improve life-saving cancer immunotherapies.

Newswise: Turbocharging CRISPR to Understand How the Immune System Fights Cancer
Released: 29-Feb-2024 8:00 AM EST
Turbocharging CRISPR to Understand How the Immune System Fights Cancer
Harvard Medical School

Harvard Medical School scientists develop new CRISPR-based tool to study the immune function of genes. New gene-editing approach could optimize how scientists study the immune system’s role in cancer and other immune-mediated diseases.

Released: 28-Feb-2024 9:05 PM EST
In fight against brain pathogens, the eyes have it
Yale University

The eyes have been called the window to the brain. It turns out they also serve as an immunological barrier that protects the organ from pathogens and even tumors, Yale researchers have found.

Newswise: cells-13-00077-ag.png?1703905384
Released: 28-Feb-2024 3:05 AM EST
Biochemists discover what affects the development of autoimmune diseases
Scientific Project Lomonosov

The biochemist of RUDN University and Institute of Biomedical Chemistry was the first to study how variants of the protein that controls T-lymphocytes affect the development of autoimmune diseases using the example of multiple sclerosis. This will help find new approaches to the treatment of autoimmune diseases.

Released: 27-Feb-2024 8:05 PM EST
Five Cutting-edge Advances in Biomedical Engineering and Their Applications in Medicine
University of California San Diego

Bridging precision engineering and precision medicine to create personalized physiology avatars. Pursuing on-demand tissue and organ engineering for human health. Revolutionizing neuroscience by using AI to engineer advanced brain interface systems. Engineering the immune system for health and wellness. Designing and engineering genomes for organism repurposing and genomic perturbations.

Newswise: How gut bacteria become ‘persisters’ to avoid antibiotics
Released: 27-Feb-2024 1:05 PM EST
How gut bacteria become ‘persisters’ to avoid antibiotics
UT Southwestern Medical Center

A subpopulation of gut bacteria given a commonly used antibiotic became "persisters" that were able to survive without developing true resistance, UT Southwestern Medical Center scientists discovered. Their findings, published in Cell Host & Microbe, could lead to better ways to fight bacterial infections.

Released: 27-Feb-2024 6:05 AM EST
Fighting the flu: The surprising power of a century-old vaccine for tuberculosis
McGill University

As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses

Released: 26-Feb-2024 9:05 PM EST
Clinical trial tests combination antibody therapy in adults with advanced cancer
Wiley

In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.

23-Feb-2024 12:05 PM EST
New Clinical Practice Guideline Provides Evidence-based Recommendations for Immunotherapy for Inhalant Allergy
American Academy of Otolaryngology - Head and Neck Surgery

The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the Clinical Practice Guideline: Immunotherapy for Inhalant Allergy today in Otolaryngology–Head and Neck Surgery.

Newswise: Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food Allergies
21-Feb-2024 12:00 PM EST
Study Led by Johns Hopkins Medicine Finds Injectable Drug Used to Treat Asthma and Other Allergic Conditions May Limit Reactions in People with Multiple Food Allergies
Johns Hopkins Medicine

A study led by Johns Hopkins Children’s Center shows omalizumab — an injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and other allergic conditions — substantially reduced potentially life-threatening reactions in patients with an allergy to peanut and other common food allergies.

Newswise: ‘Dynamic duo’ defenses in bacteria ward off viral threats
Released: 22-Feb-2024 8:05 PM EST
‘Dynamic duo’ defenses in bacteria ward off viral threats
University of Southampton

Scientists at the University of Southampton have discovered that bacteria can pair up their defense systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.

Newswise: Study Reveals New Insights Into Immune System Role in Lung Cancer Risk
19-Feb-2024 10:05 AM EST
Study Reveals New Insights Into Immune System Role in Lung Cancer Risk
Mount Sinai Health System

Recent developments in cancer research have highlighted the vital role of the immune system, particularly in the notable successes of cancer immunotherapy. Now, a paradigm-shifting study led by researchers at the Icahn School of Medicine at Mount Sinai in New York in collaboration with the University of Helsinki and Massachusetts General Hospital sheds light on how variations in immune genetics influence lung cancer risk, potentially paving the way for enhanced prevention strategies and screening. The findings were described in the February 22 online issue of Science.

Released: 22-Feb-2024 11:05 AM EST
Immune Cell Receptor Provides Promising Immunotherapy Target
Johns Hopkins Medicine

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients’ immune systems fight back against cancer, according to a study by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.



close
2.15007